Approval · Notice of Compliance 1709 · 2003
KIDROLASE: Notice of Compliance 1709
Issued August 13, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1709
- Date
- August 13, 2003
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing facility
- Therapeutic class
- Antileukemic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KIDROLASE | Not yet assigned | — |
Medicinal ingredients
- ASPARAGINASE 10,000 UNIT per VIAL